The guidelines are a first-of-its-kind effort to establish recommendations for the medical management of HS in seven ...

The prescribing information for two respiratory syncytial virus (RSV) vaccines will now include a warning for the increased ...

President Trump has vowed to impose tariffs on China, Mexico, and Canada. They could make common medicines less affordable.

The stock has spent the past few years in the shadow of a COVID-19 boost, but it's time investors see the light.

Mr Bourla does not say in the interview that COVID jabs are dangerous. The interview begins at the 35 seconds mark of the ...

The general mood among these heavyweight investors is divided, with 33% leaning bullish and 50% bearish. Among these notable ...

However, Pfizer's revenue guidance for 2025 doesn't look particularly exciting. The company expects its top line to come in ...

Pfizer Inc (PFE) stock saw a modest uptick, ending the day at $26.44 which represents a slight increase of $0.43 or 1.65% from the prior close of $26.01. The stock opened at $26.01 and touched a low ...

Pfizer Inc. ( NYSE:PFE ) will increase its dividend from last year's comparable payment on the 7th of March to ...

In 2024, companies in the broader market that paid dividends returned around 35% of their net income and 45% of their free ...

M&A activity in the F&B industry is set to rise in 2025, driven by favorable economic conditions and strategic acquisitions ...

Diabetes and weight management drugs dominated game-day NFL advertising during the regular season, with TV outcomes company ...